SS is characterized by the translocation of ss18 gene on chromosome 18 and synovial sarcoma x (SSX) gene on chromosome X (usually SSX1 or SSX2), which is the driving factor of tumorigenesis and leads to the expression of SS18-SSX fusion protein (Guillou et al., 2004). This evidence concerns the gene SSX1 and synovial sarcoma.